AMY TEJRAL

Issues related to the federal definition and regulation of hemp and hemp-derived cannabinoid products; H.R. 7024/S. 3686, Hemp Planting Predictability Act; Proposals to delay, modify, or replace the November 12, 2026 effective date of the revised hemp definition with a regulatory framework; S. 3474, Cannabinoid Safety and Regulation Act; S. 4315, Hemp Safety Enforcement Act; H.R. 7567, Farm, Food, and National Security Act of 2026 (hemp provisions); Agricultural Act of 2026 (Senate farm bill discussion draft), hemp provisions; Issues affecting hemp farmers and small businesses; H.R. 6500, Continuing Appropriations and Extensions Act, 2027

Issues related to the federal definition and regulation of hemp and hemp-derived cannabinoid products; H.R. 7024/S. 3686, Hemp Planting Predictability Act; Proposals to delay, modify, or replace the November 12, 2026 effective date of the revised hemp definition with a regulatory framework; S. 3474, Cannabinoid Safety and Regulation Act; S. 4315, Hemp Safety Enforcement Act; H.R. 7567, Farm, Food, and National Security Act of 2026 (hemp provisions); Agricultural Act of 2026 (Senate farm bill discussion draft), hemp provisions; Issues affecting hemp farmers and small businesses; H.R. 6500, Continuing Appropriations and Extensions Act, 2027

Issues related to the federal definition and regulation of hemp and hemp-derived cannabinoid products; H.R. 7024/S. 3686, Hemp Planting Predictability Act; Proposals to delay, modify, or replace the November 12, 2026 effective date of the revised hemp definition with a regulatory framework; S. 3474, Cannabinoid Safety and Regulation Act; S. 4315, Hemp Safety Enforcement Act; H.R. 7567, Farm, Food, and National Security Act of 2026 (hemp provisions); Agricultural Act of 2026 (Senate farm bill discussion draft), hemp provisions; Issues affecting hemp farmers and small businesses; H.R. 6500, Continuing Appropriations and Extensions Act, 2027

H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to genomic sequencing; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to artificial intelligence

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders; Issues related to Senate Finance Dear Colleague process

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

H.R. 842/S. 339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; Issues related to genomic sequencing; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC); Issues related to artificial intelligence

Issues related to the federal definition and regulation of hemp and hemp-derived cannabinoid products; H.R. 7024/S. 3686, Hemp Planting Predictability Act; Proposals to delay, modify, or replace the November 12, 2026 effective date of the revised hemp definition with a regulatory framework; S. 3474, Cannabinoid Safety and Regulation Act; S. 4315, Hemp Safety Enforcement Act; H.R. 7567, Farm, Food, and National Security Act of 2026 (hemp provisions); Agricultural Act of 2026 (Senate farm bill discussion draft), hemp provisions; Issues affecting hemp farmers and small businesses; H.R. 6500, Continuing Appropriations and Extensions Act, 2027

Issues related to the federal definition and regulation of hemp and hemp-derived cannabinoid products; H.R. 7024/S. 3686, Hemp Planting Predictability Act; Proposals to delay, modify, or replace the November 12, 2026 effective date of the revised hemp definition with a regulatory framework; S. 3474, Cannabinoid Safety and Regulation Act; S. 4315, Hemp Safety Enforcement Act; H.R. 7567, Farm, Food, and National Security Act of 2026 (hemp provisions); Agricultural Act of 2026 (Senate farm bill discussion draft), hemp provisions; Issues affecting hemp farmers and small businesses; H.R. 6500, Continuing Appropriations and Extensions Act, 2027

Issues related to the federal definition and regulation of hemp and hemp-derived cannabinoid products; H.R. 7024/S. 3686, Hemp Planting Predictability Act; Proposals to delay, modify, or replace the November 12, 2026 effective date of the revised hemp definition with a regulatory framework; S. 3474, Cannabinoid Safety and Regulation Act; S. 4315, Hemp Safety Enforcement Act; H.R. 7567, Farm, Food, and National Security Act of 2026 (hemp provisions); Agricultural Act of 2026 (Senate farm bill discussion draft), hemp provisions; Issues affecting hemp farmers and small businesses; H.R. 6500, Continuing Appropriations and Extensions Act, 2027

Issues related to awareness of independently-produced public broadcast programming; Issues related to H.R. 4, the Recissions Act of 2025

Issues related to awareness of independently-produced public broadcast programming; Issues related to H.R. 4, the Recissions Act of 2025

Issues related to awareness of independently-produced public broadcast programming; Issues related to H.R. 4, the Recissions Act of 2025

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025; H.R. 10545, American Relief Act, 2025

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement; Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement; Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025; H.R. 10545, American Relief Act, 2025

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; General monitoring of the 2025 NDAA

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025; H.R. 10545, American Relief Act, 2025

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; General monitoring of the 2025 NDAA

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025; H.R. 10545, American Relief Act, 2025

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025; H.R. 10545, American Relief Act, 2025

Issues related to biosecurity; H.R. 7085/S. 3558, BIOSECURE Act; H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4638, National Defense Authorization Act for Fiscal Year 2025

Inflation Reduction Act of 2022 - Part B drug negotiation and impact on physician reimbursement; Telehealth extension; Part B drug reimbursement; Issues related to site neutral payments; Issues related to healthcare access, quality and costs; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; H.R. 4822, Health Care Price Transparency Act of 2023; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency; H.R. 5526, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023

Inflation Reduction Act of 2022 - Part B drug negotiation and impact on physician reimbursement; Telehealth extension; Part B drug reimbursement; Issues related to site neutral payments; Issues related to healthcare access, quality and costs; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; H.R. 4822, Health Care Price Transparency Act of 2023; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency; H.R. 5526, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023

Inflation Reduction Act of 2022 - Part B drug negotiation and impact on physician reimbursement; Telehealth extension; Part B drug reimbursement; Issues related to site neutral payments; Issues related to healthcare access, quality and costs; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; H.R. 4822, Health Care Price Transparency Act of 2023; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency; H.R. 5526, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023

Inflation Reduction Act of 2022 - Part B drug negotiation and impact on physician reimbursement; Telehealth extension; Part B drug reimbursement; Issues related to site neutral payments; Issues related to healthcare access, quality and costs; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; H.R. 4822, Health Care Price Transparency Act of 2023; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency; H.R. 5526, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023

Inflation Reduction Act of 2022 - Part B drug negotiation and impact on physician reimbursement; Telehealth extension; Part B drug reimbursement; Issues related to site neutral payments; Issues related to healthcare access, quality and costs; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; H.R. 4822, Health Care Price Transparency Act of 2023; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency; H.R. 5526, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023

Inflation Reduction Act of 2022 - Part B drug negotiation and impact on physician reimbursement; Telehealth extension; Part B drug reimbursement; Issues related to site neutral payments; Issues related to healthcare access, quality and costs; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; H.R. 4822, Health Care Price Transparency Act of 2023; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency; H.R. 5526, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023

Inflation Reduction Act of 2022 - Part B drug negotiation and impact on physician reimbursement; Telehealth extension; Part B drug reimbursement; Issues related to site neutral payments; Issues related to healthcare access, quality and costs; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; H.R. 4822, Health Care Price Transparency Act of 2023; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; CMS Guidance on the Impact of the End of the COVID-19 Public Health Emergency and National Emergency; H.R. 5526, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; S.377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule, issued 6/21/22

Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Issues related to the Public Health Emergency; S. 368/H.R. 1332, Telehealth Modernization Act; Issues related to the implementation of the No Surprises Act; Issues related to the FY 2023 Presidents Budget; H.R. 2163/S.464 - Safe Step Act of 2021 S.4293, Pharmacy Benefit Manager Transparency Act of 2022

Health disparities; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; H.R. 5376, Build Back Better; Issues related to the Public Health Emergency; S. 368/H.R. 1332, Telehealth Modernization Act; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Issues related to the implementation of the No Surprises Act; Issues related to the FY 2023 Presidents Budget; H.R. 2163/S. 464, Safe Step Act of 2021; S. 4293, Pharmacy Benefit Manager Transparency Act of 2022

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; S.377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule, issued 6/21/22

Issues related to S. 243, the Legacy IRA Act; Issues related to S. 618, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 1704, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 2954, Securing a Strong Retirement Act of 2021, as it related to the expansion of the IRA Charitable Rollover

Issues related to S. 243, the Legacy IRA Act; Issues related to S. 618, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 1704, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 2954, Securing a Strong Retirement Act of 2021, as it related to the expansion of the IRA Charitable Rollover

Issues related to S. 243, the Legacy IRA Act; Issues related to S. 618, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 1704, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 2954, Securing a Strong Retirement Act of 2021, as it related to the expansion of the IRA Charitable Rollover

Issues relating to privacy and the use of data, particularly as they relate to the use of such data by nonprofit organizations; H.R. 1816, the Information Transparency & Personal Data Control Act; H.R. 8152, the American Data Privacy & Protection Act

Issues relating to privacy and the use of data, particularly as they relate to the use of such data by nonprofit organizations; H.R. 1816, the Information Transparency & Personal Data Control Act

Issues relating to privacy and the use of data, particularly as they relate to the use of such data by nonprofit organizations; H.R. 1816, Information Transparency & Personal Data Control Act; H.R. 8152, American Data Privacy & Protection Act

Issues relating to privacy and the use of data, particularly as they relate to the use of such data by nonprofit organizations; H.R. 1816, Information Transparency & Personal Data Control Act; H.R. 8152, American Data Privacy & Protection Act

Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Issues related to the Public Health Emergency; S. 368/H.R. 1332, Telehealth Modernization Act; Issues related to the implementation of the No Surprises Act; Issues related to the FY 2023 Presidents Budget; H.R. 2163/S.464 - Safe Step Act of 2021 S.4293, Pharmacy Benefit Manager Transparency Act of 2022

Health disparities; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; H.R. 5376, Build Back Better; Issues related to the Public Health Emergency; S. 368/H.R. 1332, Telehealth Modernization Act; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Issues related to the implementation of the No Surprises Act; Issues related to the FY 2023 Presidents Budget; H.R. 2163/S. 464, Safe Step Act of 2021; S. 4293, Pharmacy Benefit Manager Transparency Act of 2022

Value of prescription drugs; Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act; Extension of the Medicare Sequester; S. 748, Medicare Sequester Relief Act; Telehealth Expansion Act; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Proposed repeal of the CMS Rule on Most Favored Nation Model; Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model

Value of prescription drugs; Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act; Extension of the Medicare Sequester; S. 748, Medicare Sequester Relief Act; Telehealth Expansion Act; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Proposed repeal of the CMS Rule on Most Favored Nation Model; Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model; Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage; S.3018/HR.3173, Improving Seniors Timely Access to Care Act of 2021

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; S.377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule, issued 6/21/22

Issues related to S. 243, the Legacy IRA Act; Issues related to S. 618, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 1704, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 2954, Securing a Strong Retirement Act of 2021, as it related to the expansion of the IRA Charitable Rollover

Issues related to S. 243, the Legacy IRA Act; Issues related to S. 618, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 1704, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 2954, Securing a Strong Retirement Act of 2021, as it related to the expansion of the IRA Charitable Rollover

Issues related to S. 243, the Legacy IRA Act; Issues related to S. 618, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 1704, Universal Giving Pandemic Response and Recovery Act; Issues related to H.R. 2954, Securing a Strong Retirement Act of 2021, as it related to the expansion of the IRA Charitable Rollover

Value of prescription drugs; Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act; Extension of the Medicare Sequester; S. 748, Medicare Sequester Relief Act; Telehealth Expansion Act; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Proposed repeal of the CMS Rule on Most Favored Nation Model; Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model; Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage; S.3018/HR.3173, Improving Seniors Timely Access to Care Act of 2021

Value of prescription drugs; Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act; Extension of the Medicare Sequester; S. 748, Medicare Sequester Relief Act; Telehealth Expansion Act; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Proposed repeal of the CMS Rule on Most Favored Nation Model; Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model

Issues related to S. 1720, Postal Service Reform Act of 2021; Issues related to H.R. 3076, Postal Service Reform Act of 2021; Issues related to S. 145, the USPS Fairness Act; Issues related to H.R. 695, the USPS Fairness Act; Any legislation regarding a new study by the Postal Regulatory Commission on the structure of postal rates

Value of prescription drugs; Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act; Extension of the Medicare Sequester; S. 748, Medicare Sequester Relief Act; Telehealth Expansion Act; Telehealth issues related to COVID-19; S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021; Proposed repeal of the CMS Rule on Most Favored Nation Model; Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model; Issues related to the OIG, GAO, MedPAC reports on Medicare Advantage; S.3018/HR.3173, Improving Seniors Timely Access to Care Act of 2021

Issues related to broadband, rural broadband, and the ReConnect Program; Issues related to H.R. 3816, American Choice and Innovation Online Act

Issues related to broadband, rural broadband, and the ReConnect Program; Issues related to H.R. 3816, American Choice and Innovation Online Act

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; S.377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule, issued 6/21/22

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; End-Stage Renal Disease (ESRD) payment reform and quality metrics; S.377/H.R. 1255, Living Donor Protection Act; H.R. 1676, Jack Reynolds Memorial Medigap Expansion Act H.R. 3893, Coordination, Accountability, Research and Equity for All Kidneys Act of 2021 (CARE for All Kidneys Act); H.R. 2934, Renal Anemia Innovation Support and Expansion (RAISE) Act; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule, issued 6/21/22

Issues related to End Stage Renal Disease and Chronic Kidney Disease; End Stage Renal Disease (ESRD) Prospective Payment System (PPS) and utilization of calcimimetic drugs S. 1971, Chronic Kidney Disease Improvement in Research and Treatment Act of 2021; H.R. 4065, To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes; Medicare Secondary Payer; H.R. 7878/S. 4307 Kidney Health Connect Act of 2022; Calendar Year 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule, issued 6/21/22

Health information technology & healthcare privacy issues; Issues related to privacy in the healthcare space; Issues related to national health information technology standards; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; H.R. 5376, Build Back Better Act; Consolidated Appropriations Act, 2022 (PL 117-103); S.3799, PREVENT Pandemics Act; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to the Senate Finance report on mental health and mental health legislation; Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services; Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP; Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022 Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S.3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; Issues related to the FY 2023 Presidents Budget; S.4293, Pharmacy Benefit Manager Transparency Act of 2022; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act; Monitor Conference negotiations between H.R. 4521, the America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to include sec 80303

Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Telehealth issues related to COVID-19; Continued monitoring of Provider Relief Fund; H.R.5376, Build Back Better Act; Issues related to the Public Health Emergency; Issues related to the implementation of the No Surprises Act; Issues related to the FY 2023 Presidents Budget

Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; H.R. 5376, Build Back Better Act; S.3799, PREVENT Pandemics Act; Issues related to the Senate Finance report on mental health and mental health legislation; Senate Finance Committee bipartisan Discussion Draft: Ensuring Access to Telemental Health Services; Senate Finance Committee bipartisan Discussion Draft: Improving Access to Physical and Mental Health Care for Children and Youth under Medicaid and CHIP; Bipartisan Safer Communities Act, P.L. 117-159, specifically policy related to access to mental health services for youth and families through Medicaid and CHIP and telehealth; H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022; Issues related to the Public Health Emergency

Health disparities; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; H.R. 5376, Build Back Better; Issues related to the Public Health Emergency; S. 368/H.R. 1332, Telehealth Modernization Act; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Issues related to the implementation of the No Surprises Act; Issues related to the FY 2023 Presidents Budget; H.R. 2163/S. 464, Safe Step Act of 2021; S. 4293, Pharmacy Benefit Manager Transparency Act of 2022